<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01642784</url>
  </required_header>
  <id_info>
    <org_study_id>2.0, 2011-11-24</org_study_id>
    <nct_id>NCT01642784</nct_id>
  </id_info>
  <brief_title>Complete Infarct Related Artery Revascularization in Acute Myocardial Infarction</brief_title>
  <acronym>CORAMIreg</acronym>
  <official_title>Complete Infarct Related Artery Revascularization in Acute Myocardial Infarction Registry(CORAMIreg)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fundacja Ośrodek Badań Medycznych</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fundacja Ośrodek Badań Medycznych</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Objective of this registry study is to compare strategy of complete vs. target lesion-only&#xD;
      primary PCI (percutaneous coronary intervention) in IRA (infarct related artery) in STEMI (ST&#xD;
      elevation myocardial infarction) patients.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      CORAMI is a registry study addressing the issue of complete vs culprit-only PCI within&#xD;
      infarct related artery in patients with ST-elevation and non-ST elevation myocardial&#xD;
      infarction treated with interventional procedures.&#xD;
&#xD;
      The main objectives of the study include:&#xD;
&#xD;
        1. gathering data on patients with at least two independent critical stenotic lesions in&#xD;
           IRA (one of which is the culprit lesion) during index primary PCI for STEMI or NSTEMI&#xD;
           (prevalence, characteristic, predisposing factors).&#xD;
&#xD;
        2. comparing chosen treatment strategies for multiple lesion IRA&#xD;
&#xD;
        3. comparison of complete vs. target lesion-only PCI in IRA in acute MI (myocardial&#xD;
           infarction) patients.&#xD;
&#xD;
      The study clinical hypothesis is that stenting single critical - culprit lesion in&#xD;
      multi-lesion IRA in MI patients during index PCI procedure is superior to stenting all&#xD;
      critical lesions in IRA in terms of early treatment result and might be associated with less&#xD;
      frequent periprocedural angiographic complications.&#xD;
&#xD;
      H0: The efficacy in terms of early treatment result of stenting one critical - culprit lesion&#xD;
      in multilesions IRA in acute MI patients is less or equal to efficacy of stenting all&#xD;
      critical lesions in IRA.&#xD;
&#xD;
      H1: The efficacy in terms of early treatment result of stenting one critical - culprit lesion&#xD;
      in multilesions IRA in acute MI patients is greater than efficacy of stenting all critical&#xD;
      lesions in IRA.&#xD;
&#xD;
      CORAMI Registry is a prospective, international (Poland, Slovenia), multicenter observational&#xD;
      study with retrospective chart review which will be performed in experienced invasive&#xD;
      facility centres with 24/7 PCI duty and continuous patient enrollment for 18 months (January&#xD;
      2011 - June 2012).&#xD;
&#xD;
      This study will collect data on all consecutive patients with STEMI and NSTEMI undergoing&#xD;
      immediate coronary angiography which demonstrated at least two independent (requiring two&#xD;
      stent platforms) critical lesions in infarct related artery (one of which is considered as&#xD;
      target/culprit lesion that have caused the myocardial infarction and requires immediate PCI).&#xD;
      Patients will be treated (multiple or single lesion stenting) according to local standard and&#xD;
      operator's decision. Patient follow up phone call and/or visit (according to local protocols)&#xD;
      will be performed at 12 months from enrollment if applicable by local standards.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2011</start_date>
  <completion_date type="Actual">July 2013</completion_date>
  <primary_completion_date type="Actual">July 2013</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Death</measure>
    <time_frame>At 12 months</time_frame>
    <description>Death rates at 12-month clinical follow-up</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Stent thrombosis</measure>
    <time_frame>At 12 months</time_frame>
    <description>Rates of stent thrombosis at 12-month follow-up according to ARC definition</description>
  </primary_outcome>
  <primary_outcome>
    <measure>reMI (repeat myocardial infarctions)</measure>
    <time_frame>At 12 months</time_frame>
    <description>Rates of reMI at 12 months</description>
  </primary_outcome>
  <primary_outcome>
    <measure>urgent TVR (target vessel revascularization) at 12 months</measure>
    <time_frame>12 months and at 12 months</time_frame>
    <description>Rates of urgent TVR at 12 months</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Planned TVR</measure>
    <time_frame>At 12 months</time_frame>
    <description>Rates of planned TVR (PCI + CABG) at 12 months</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Angiographic complications</measure>
    <time_frame>During hospitalization</time_frame>
    <description>Immediate in-hospital angiographic complications (at least one or more of the following: distal embolisation, no-reflow, slow-flow, acute coronary artery occlusion, artery perforation, tamponade, dissection type B and above)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Target Vessel Revascularization (PCI and/or CABG (coronary artery bypass graft))</measure>
    <time_frame>During hospitalization and at 12 months</time_frame>
    <description>Urgent in-hospital Target Vessel Revascularization (PCI and/or CABG)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complete contrast dose in ml</measure>
    <time_frame>During hospitalization and at 12 months</time_frame>
    <description>Complete contrast dose in ml</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complete radiation dose in mGy</measure>
    <time_frame>During hospitalization and at 12 months</time_frame>
    <description>Complete radiation dose in mGy</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">100</enrollment>
  <condition>Myocardial Infarction</condition>
  <arm_group>
    <arm_group_label>Culprit lesion IRA revascularization</arm_group_label>
    <description>Culprit lesion IRA revascularization</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Complete IRA revascularization</arm_group_label>
    <description>Complete IRA revascularization</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Primary PCI of culprit lesion in IRA with drug eluting stent (DES)</intervention_name>
    <description>Primary PCI of culprit lesion in IRA with drug eluting stent (DES)</description>
    <arm_group_label>Culprit lesion IRA revascularization</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Primary PCI of culprit lesion in IRA with drug eluting stent (DES) and PCI of the other critical lesion in IRA with another DES</intervention_name>
    <description>Primary PCI of culprit lesion in IRA with drug eluting stent (DES) and PCI of the other critical lesion in IRA with another DES</description>
    <arm_group_label>Complete IRA revascularization</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Study population will comprise of approx. 200 patients (males and females) with the&#xD;
        diagnosis of STEMI or NSTEMI and at least two independent critical lesions in infarct&#xD;
        related artery (one of which is considered as target/culprit lesion that have caused the&#xD;
        myocardial infarction and requires immediate PCI). Patients enrolled to the registry must&#xD;
        meet all the eligibility criteria.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Diagnosis of STEMI or NSTEMI (according to ESC 2007 definition)&#xD;
&#xD;
          -  Over 18 years of age&#xD;
&#xD;
          -  Presence of two critical lesions requiring PCI in IRA (LAD (left anterior descending),&#xD;
             Cx (circumflex), RCA (right coronary artery)):&#xD;
&#xD;
               1. Target/culprit lesion which requires immediate stenting (&gt;50 - 100%) and&#xD;
&#xD;
               2. Second critical lesion (70-90%).&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Terminal illness with life expectancy less &lt;1 year or active cancer disease,&#xD;
&#xD;
          -  Pregnancy or possibility of pregnancy&#xD;
&#xD;
          -  Second critical lesion in IRA &gt;90% or occlusion&#xD;
&#xD;
          -  Contraindications to PCI or/and stent implantation&#xD;
&#xD;
          -  Con-current participation in another clinical study that did not meet its primary&#xD;
             end-point&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bogdan Januś, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Pracownia Hemodynamiki Szpital im. E. Szczeklika</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Krakowskie centrum Kardiologii Inwazyjnej, Elektroterapii i Angiologii, Carint Scanmed Sp. z o.o.</name>
      <address>
        <city>Kraków</city>
        <zip>30-693</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centrum Kardiologii Inwazyjnej GVM Carint</name>
      <address>
        <city>Ostrowiec Swietokrzyski</city>
        <zip>27-400</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centrum Kardiologii Inwazyjnej GVM Carint</name>
      <address>
        <city>Oświecim</city>
        <zip>32-600</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Oddział Kardiologii Inwazyjnej, Elektroterapii i Angiologii w Pińczowie</name>
      <address>
        <city>Pinczow</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Podkarpackie Centrum Interwencji Sercowo -Naczyniowych NZOZ</name>
      <address>
        <city>Sanok</city>
        <zip>38-500</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pracownia Hemodynamiki Szpital im. E. Szczeklika</name>
      <address>
        <city>Tarnów</city>
        <zip>33-100</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>I Katedra i Klinika Kardiologii, Warszawski Uniwersytet Medyczny</name>
      <address>
        <city>Warszawa</city>
        <zip>02-097</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Departament of Cardiology, University Hospital, Ljubljana</name>
      <address>
        <city>Ljubljana</city>
        <country>Slovenia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Poland</country>
    <country>Slovenia</country>
  </location_countries>
  <verification_date>July 2013</verification_date>
  <study_first_submitted>June 25, 2012</study_first_submitted>
  <study_first_submitted_qc>July 15, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 17, 2012</study_first_posted>
  <last_update_submitted>July 2, 2013</last_update_submitted>
  <last_update_submitted_qc>July 2, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 3, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>STEMI</keyword>
  <keyword>NSTEMI</keyword>
  <keyword>revascularization</keyword>
  <keyword>stents</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Myocardial Infarction</mesh_term>
    <mesh_term>Infarction</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

